Technology

  Market Overview According to Market Genics , the AI in Clinical Trials Market is estimated to be valued at USD 1.1 Billion in 2025 and is projected to reach USD 2.7 Billion by 2035 , expanding at a CAGR of 9.2% during the forecast period. The market is witnessing rapid growth as pharmaceutical companies, biotechnology firms, contract research organizations (CROs), and healthcare institutions increasingly adopt artificial intelligence to accelerate drug development and improve clinical trial efficiency. AI technologies such as machine learning (ML), natural language processing (NLP), computer vision, predictive analytics, and generative AI are transforming clinical trial processes by enhancing patient recruitment, optimizing trial design, improving protocol compliance, predicting trial outcomes, and reducing operational costs. Growing investments in precision medicine, decentralized clinical trials (DCTs), digital health platforms, and AI-powered data analytics are furth...